52 years male, weighed 70kgs was planned for open
epigastric hernioplasty. He was a chronic smoker with diabetic, hypertensive
and hypercholestrolemia. He was a known case of coronary artery disease (CAD),
with post percutaneous transluminal coronary angioplasty (PTCA) with global
regional wall motion abnormality (RWMA), Ejection fraction 35%, Grade II left
ventricular systolic dysfunction. He was on oral hypoglycemic drugs,
antihypertensive drugs and statins. Tablet aspirin was stopped 5 days prior to
surgery. Cardiologist categorized this case under intermediate risk procedure
after cardiac assessment. Considering other comorbidities, written informed
high risk consent has taken. Routine standard monitoring was done. Intravenous
18G cannula secured in left upper limb. Lacted ringer solution infused. After
100% preoxygenation, he was induced with intravenous (IV) glycopyrolate 0.2 mg,
IV ondansatron 4 mg, IV midazolam 1mg, IV morphine 3mg, IV etomidate 16mg and IV
remifentanyl 30 micrograms bolus. Size four I-gel supraglottic airway device
was inserted and connected to ventilator on volume control mode with 500ml
tidal volume, respiratoy rate 14/min and pressure support of 12. IV
cisatracurium 12mg bolus given. He was on oxygen, air, Sevoflurane and titrated
dosage of morphine to maintain sinus rhythm, normotension and desirable MAC
(Figure 1).

Figure
1:
Rectus sheath block, with depiction of needle position and location of local
anesthetic injection.
Intraoperatively 500 ml of lactated solution infused
intravenously. Under all aseptic conditions, USG guided bilateral rectus sheath
block has given with 20 ml of 0.5% bupivaccaine plus morphine 3mg.
Intraoperative period was uneventful. At the end of surgery he was reversed
with IV neostigmine 2.5 mg with IV glycopyrolate 0.4 mg and extubated smoothly
without significant pressor response. Post operatively patient was free from
pain as well as respiration was smooth and regular.